Login to Your Account


In a bit of regulatory house cleaning, the FDA is tossing a few obsolete or duplicative rules for certain biologics-makers and reducing the need for animal testing.

NEW DELHI – India has launched a pharmaceutical price databank to be managed and operated by its drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), to help consumers make informed product formulation and rate choices.
The Supreme Court has ruled on the latest issue surrounding patent licensing, essentially holding with precedent in a case the court reviewed roughly half a century ago.
More REGULATORY Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: